SCHEDULE 13D FILED BY MILLS VALUE ADVISER, INC.

Company

Inhibitor Therapeutics, Inc.

Filed

November 5, 1997

Accession Number

0001002105-97-000125

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →